The document proposes an Enterprise 2.0 project called ALK Enterprise 2.0 Platform to improve patient adherence through a social approach. It involves building online communities for patients, physicians, and ALK employees on websites like www.allergia.it, www.wikialk.it, and www.wikiallergia.it. These sites would provide disease management resources and integrate data from ALK's customer relationship and order fulfillment systems to better track patient adherence and support multiple touchpoints along a patient's treatment journey.